ARCHIVE: Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
press releaseinvestorvideoARCHIVE
ARCHIVE: Invizyne’s Nasdaq IPO Marks New Era of BiomanufacturingNovember 13, 2024
ARCHIVE: Invizyne Technologies Begins Trading on NASDAQ
press releaseinvestorARCHIVE
ARCHIVE: Invizyne Technologies Begins Trading on NASDAQNovember 13, 2024
ARCHIVE: Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
press releaseinvestorARCHIVE
ARCHIVE: Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024November 12, 2024
ARCHIVE: Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
press releaseinvestorARCHIVE
ARCHIVE: Invizyne Technologies Announces Pricing of $15 Million Initial Public OfferingNovember 11, 2024
ARCHIVE: With NREL's Help, GCxN Company Readies for Initial Public Offering
press clippingsARCHIVE
ARCHIVE: With NREL's Help, GCxN Company Readies for Initial Public OfferingSeptember 30, 2024
NREL
biofuelinvestorscienceARCHIVE
ARCHIVE: NREL (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project - a fireside chatAugust 2, 2024
ARCHIVE: Commercializing Invizyne’s cell-free platform - fireside chat with Zachary Karl, PhD, VP of BizDev - and - Lou Basenese
investorvideoARCHIVE
ARCHIVE: Commercializing Invizyne’s cell-free platform - fireside chat with Zachary Karl, PhD, VP of BizDev - and - Lou BaseneseJuly 30, 2024
ARCHIVE: Invizyne IPO: interview with Dr. James J. Lalonde by MDB Capital President and Chief Market Strategist Lou Basenese
investorvideoARCHIVE
ARCHIVE: Invizyne IPO: interview with Dr. James J. Lalonde by MDB Capital President and Chief Market Strategist Lou BaseneseJuly 17, 2024
ARCHIVE: MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies
press releaseinvestorARCHIVE
ARCHIVE: MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne TechnologiesJuly 11, 2024
ARCHIVE: CEO Michael Heltzen and Co-Founder & VP of Research Dr. Tyler Korman present the Invizyne story and IPO opportunity to investors
investorvideoARCHIVE
ARCHIVE: CEO Michael Heltzen and Co-Founder & VP of Research Dr. Tyler Korman present the Invizyne story and IPO opportunity to investorsJune 18, 2024
Previous page
Page 11 of 13
Next page